Malignant Peritoneal Neoplasm Terminated Phase 2 Trials for Pemetrexed (DB00642)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00055432Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal CancerTreatment